Stock LCI LANNETT COMPANY, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Lannett Company, Inc.

Equities

LCI

US5160122009

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
LANNETT COMPANY, INC. FILES PREPACKAGED CHAPTER 11 CASES TO SIGNIFICANTLY STRENGTHEN FINANCIAL POSITION
PR
Lannett Company, Inc. Enters Into Restructuring Support Agreement
PR
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS
PR
LANNETT CO INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
LANNETT CO INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
LANNETT SHARES UPDATE
PR
Lannett : Modification to Rights of Security Holders - Form 8-K
PU
LANNETT CO INC : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
LANNETT CO INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
LANNETT CO INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Lannett: Fiscal Q2 Earnings Snapshot
AQ
LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCE
PR
Lannett : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
LANNETT CO INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLIT
PR
LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1
PR
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS
PR
LANNETT CO INC : Costs Associated with Exit or Disposal Activities, Material Impairments (form 8-K)
AQ
LANNETT CO INC : Entry into a Material Definitive Agreement (form 8-K)
AQ
LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAM
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LCI Stock
  4. News Lannett Company, Inc.
  5. Press Releases